KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Dividends payables (2016 - 2026)

Abbott Laboratories' Dividends payables history spans 18 years, with the latest figure at $1.1 billion for Q1 2026.

  • On a quarterly basis, Dividends payables rose 6.59% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 6.59% increase, with the full-year FY2025 number at $1.1 billion, up 7.13% from a year prior.
  • Dividends payables hit $1.1 billion in Q1 2026 for Abbott Laboratories, roughly flat from $1.1 billion in the prior quarter.
  • Over the last five years, Dividends payables for ABT hit a ceiling of $1.1 billion in Q1 2026 and a floor of $820.0 million in Q3 2022.
  • Historically, Dividends payables has averaged $950.4 million across 5 years, with a median of $956.0 million in 2024.
  • Biggest five-year swings in Dividends payables: grew 2.87% in 2022 and later increased 8.24% in 2024.
  • Tracing ABT's Dividends payables over 5 years: stood at $887.0 million in 2022, then rose by 7.67% to $955.0 million in 2023, then rose by 7.23% to $1.0 billion in 2024, then increased by 7.13% to $1.1 billion in 2025, then grew by 0.27% to $1.1 billion in 2026.
  • Business Quant data shows Dividends payables for ABT at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.0 billion in Q3 2025.